Navigation Links
Gateway for Cancer Research Announces New Grant Program for Clinical Trials Informed by Mobile Technology and Telemedicine
Date:5/30/2020

Gateway for Cancer Research (Gateway), a nonprofit organization dedicated to funding transformational early-phase cancer research, is excited to announce the launch of a new grant program to fund clinical trials leveraging mobile technology and telemedicine to advance cancer science and care.

The COVID-19 pandemic has resulted in significant disruption to clinical trial access for patients on or seeking investigational cancer treatment. Social distancing policies, patient concerns regarding travel to clinical settings for treatment and tactics to mitigate COVID-19 transmission at provider institutions have led to delays and the suspension of clinical studies at cancer centers in the U.S. and abroad.

The pandemic has underscored significant vulnerabilities to the centralized model of clinical studies in which the patient must “go to the trial.” Gateway is providing grants in the range of $400,000 to $600,000 for early-phase clinical studies that advance technology-informed decentralized trial strategies. These may include telemedicine, wearables, remote monitoring, mobile nursing, or other strategies that bring the trial directly to the patient. Applications are being accepted now through June 22, 2020 and the recipients will be notified on July 30, 2020.

“At Gateway, patients are at the center of everything we do and the impact of the pandemic on their access to clinical trials has been deeply troubling,” said Michael Burton, President and CEO of Gateway for Cancer Research. “The field clearly needs more robust methods and tools to ensure continuity of access to investigational therapies during this pandemic and beyond. To that end, we are pleased to announce this funding opportunity to accelerate decentralized clinical studies that put the patient at the center of trial design.”    

To learn more or apply for a grant, please visit GatewayCR.org/Research or email Research@GatewayCR.org.

About Gateway for Cancer Research
Gateway for Cancer Research is a nonprofit 501c(3) organization committed to funding innovative cancer research that helps people living with cancer to feel better and live longer as we work to end cancer as we know it. Thanks to generous underwriting, 99 cents of every dollar Gateway receives directly funds Phase I and Phase II cancer clinical trials at leading research institutions across the country and abroad. Since 1991, Gateway has supported more than 180 clinical trials and funded over $90 million in breakthrough cancer research. Get involved today by visiting GatewayCR.org, like us on Facebook and join the conversation on Twitter and Instagram, #BeAGateway.

Read the full story at https://www.prweb.com/releases/gateway_for_cancer_research_announces_new_grant_program_for_clinical_trials_informed_by_mobile_technology_and_telemedicine/prweb17158936.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related medicine technology :

1. Gateway Analytical to Exhibit Pharmaceutical Forensic Services at the American Association of Pharmaceutical Scientist Annual Meeting in San Antonio
2. Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit
3. Gateway Rehab and the Kenneth S. Ramsey, PhD Research and Training Institute expand Naloxone: Increasing Access, Saving Lives research project to outpatient locations
4. Gateway Health And Wellbridge Health Announce Partnership To Provide Healthcare Innovative Solutions to Gateway Membership
5. Allegheny Health Network, Gateway Health Launch New Holistic Program for Patients with Chronic Pain and Opioid Addiction
6. Gateway Genomics Achieves Milestone of 100,000 SneakPeek Early Gender DNA Tests Sold
7. DHL Improves Operations at Its Chicago Gateway with Smart Monitoring and Inventory Technologies
8. Arno Therapeutics to Present Positive, New Data Supporting the Potential of Onapristone in Endometrial and Breast Cancers at ASCO 2013 Annual Meeting
9. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
10. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
11. RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2020)... ... June 19, 2020 , ... With the success of ... Warrior Gym at in Queen Creek. Since the foundation of the Conquer Ninja Gyms ... essence, all of the gym locations still share the vision of Jake Marshman, who ...
(Date:6/19/2020)... , ... June 19, 2020 ... ... of its cross-platform campaign 'Clinical Trials.' This campaign showcases the innovative medical ... these studies, thereby advancing knowledge and disease treatment. This public awareness campaign ...
(Date:6/19/2020)... ... June 19, 2020 , ... American Health Technology Group (AHTG), ... pioneer and leader in healthcare workforce solutions, will provide staffing support and other ... States. AHTG and AHSA are part of the American Health Staffing Group (AHSG) ...
Breaking Medicine Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... ... botanically-derived terpenes, has officially released its new terpene infused product line including ... for consumers to enjoy cannabis terpene profiles and flavors worldwide. , “We’ve made ...
(Date:7/1/2020)... ... July 01, 2020 , ... The Society to ... of Medicine at the University of Massachusetts Medical School- Baystate and Ann Gaffey, ... the SIDM Board of Directors. Dr. Salvador and Ms. Gaffey’s service began in ...
(Date:6/28/2020)... ... 26, 2020 , ... The Pool & Hot Tub Alliance ... the ANSI/APSP/ICC-7 2013 American National Standard for Suction Entrapment Avoidance In Swimming Pools, ... on the PHTA-7 Standard Writing Committee (SWC) for Suction Entrapment Avoidance in Swimming ...
(Date:6/28/2020)... ... ... PathAI, a global provider of artificial intelligence (AI)-powered technology for use in pathology research, ... to assess response in patients treated with Bristol Myers Squibb’s PD-1 inhibitor, nivolumab was ... Annual Meeting. AACR was held June 22 to June 24. , The key finding ...
(Date:6/28/2020)... ... , ... The Coronavirus pandemic created shortages in Personal Protection ... top-quality masks, sanitizers and thermometers, Trusted PPE is a woman and minority-owned company, ... of our masks are manufactured to medical standards in FDA-certified factories, which ensures ...
Breaking Medicine News(10 mins):